Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.69 |
| ▸ | MMP2 | P08253 | 1/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | ALB | P02768 | 1/20 | 0.51 |
| ▸ | LTA4H | P09960 | 2/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.50 |
| ▸ | PPARA | Q07869 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1271045 | 0.90 | ESR1 (0.59) | L3MBTL1FFAR1ALBLTA4HESR1 | |
| SCHEMBL2158826 | 0.86 | ALB (0.68) | ALBESR1NR5A1PPARA | |
| SCHEMBL7747968 | 0.86 | ALB (0.68) | ALBESR1NR5A1PPARA | |
| SCHEMBL12534514 | 0.86 | ALB (0.68) | ALBESR1NR5A1PPARA | |
| SCHEMBL2494017 | 0.85 | ALB (0.66) | ALBESR1NR5A1PPARA | |
| SCHEMBL9714152 | 0.83 | L3MBTL1 (0.54) | L3MBTL1MMP2FFAR1TSHRALB | |
| SCHEMBL38674 | 0.83 | L3MBTL1 (0.68) | L3MBTL1MMP2FFAR1LMNATSHR | |
| Mequinol SCHEMBL10533614 | 0.82 | PDE4B (0.57) | L3MBTL1FFAR1ALBESR1PPARA | |
| SCHEMBL19043148 | 0.82 | L3MBTL1 (0.72) | L3MBTL1MMP2FFAR1LMNA | |
| SCHEMBL1806524 | 0.82 | L3MBTL1 (1.00) | L3MBTL1MMP2FFAR1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109651140-A | A kind of synthetic method of cyhalofop-butyl active compound | 江苏中旗科技股份有限公司 | 2019-04-19 | — | — | CN | claimed |
| US-9573965-B2 | Process for the preparation of Dolutegravir | AUROBINDO PHARMA LTD (IN) | 2017-02-21 | — | — | US | claimed |
| US-20160108058-A1 | An improved process for the preparation of Dolutegravir | AUROBINDO PHARMA LTD. (IN) | 2016-04-21 | — | — | US | claimed |
| JP-4776846-B2 | — | — | 2011-09-21 | — | — | JP | claimed |
| US-7078226-B1 | Method for producing optically active amines | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-18 | — | — | US | claimed |
| EP-1232279-B1 | METHOD FOR PRODUCING OPTICALLY ACTIVE AMINES | BASF AG (DE) | 2005-03-02 | — | — | EP | claimed |
| EP-1232279-A2 | METHOD FOR PRODUCING OPTICALLY ACTIVE AMINES | BASF AKTIENGESELLSCHAFT (DE) | 2002-08-21 | — | — | EP | claimed |
| WO-2001038292-A2 | METHOD FOR PRODUCING OPTICALLY ACTIVE AMINES | BASF AKTIENGESELLSCHAFT (DE) | 2001-05-31 | — | — | WO | claimed |
| EP-0539274-B1 | Method for the synthesis of aldehydes and of their derivatives | RHONE POULENC CHIMIE (FR) | 1996-04-10 | — | — | EP | claimed |
| EP-0383613-A2 | Optically active lactate, derivatives thereof and processes of producing same | Tosoh Corporation (JP) | 1990-08-22 | — | — | EP | claimed |
| JP-2304076-A | — | — | None | — | — | JP | disclosed |
| CN-119240903-A | Wastewater treatment method based on improved wet oxidation reaction | 南京工业大学 | 2025-01-03 | — | — | CN | disclosed |
| EP-4330382-A2 | IN VITRO DRUGS FROM PRODRUGS AND USE THEREOF | Brandenburgische Technische Universität Cottbus-Senftenberg (DE) | 2024-03-06 | — | — | EP | disclosed |
| CN-115721995-A | Production system and process of cyhalofop-butyl technical material | 池州飞昊达化工有限公司 | 2023-03-03 | — | — | CN | disclosed |
| WO-2022229050-A2 | IN VITRO DRUGS FROM PRODRUGS AND USE THEREOF | BRANDENBURGISCHE TECHNISCHE UNIVERSITÄT COTTBUS-SENFTENBERG (DE) | 2022-11-03 | — | — | WO | disclosed |
| EP-0139252-A2 | Esterification of carboxylic acids containing phenol groups | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-05-02 | — | — | EP | disclosed |
| EP-0138359-A2 | Herbicidal Fluorophenoxyphenoxypropionates, derivatives thereof and related compounds | THE DOW CHEMICAL COMPANY (US) | 1985-04-24 | — | — | EP | disclosed |
| US-4336057-A | Herbicides | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-06-22 | — | — | US | disclosed |
| US-4325729-A | Herbicidal and plant growth regulating pyridyloxy-phenoxy-propionic acid derivatives | CIBA-GEIGY CORPORATION (US) | 1982-04-20 | — | — | US | disclosed |
| WO-1979000094-A1 | HERBICIDAL PYRIDINE COMPOUNDS | ICI LTD (GB) | 1979-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160108058-A1 | An improved process for the preparation of Dolutegravir | XDH, TBK1, POLR2H | L3MBTL1 4146/4885MMP2 2839/4885FFAR1 1608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.